Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
221
-
Total 13F shares, excl. options
-
65.6M
-
Shares change
-
-392K
-
Total reported value, excl. options
-
$3.49B
-
Value change
-
-$15.4M
-
Number of buys
-
96
-
Number of sells
-
-113
-
Price
-
$53.24
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2014
243 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2014.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 221 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.6M shares
of 71.9M outstanding shares and own 91.13% of the company stock.
Largest 10 shareholders include Neuberger Berman Group LLC (5.61M shares), VANGUARD GROUP INC (5.5M shares), FRANKLIN RESOURCES INC (4.45M shares), BlackRock Fund Advisors (3.99M shares), State Street Corp (3.17M shares), BAMCO INC /NY/ (2.49M shares), KALMAR INVESTMENTS INC /DE/ (2.3M shares), RS INVESTMENT MANAGEMENT CO LLC (2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.93M shares), and ROYAL BANK OF CANADA (1.75M shares).
This table shows the top 221 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.